3-Pyridin-4-yl-quinoxaline-2-carboxylic acid, 95.0%, 1g

1-(Tetrahydro-2H-pyran-2-yl)-1H-indazole-5-carboxylic acid, 95.0%, 250mg

Methyl 4-aminothiophene-3-carboxylate hydrochloride, 95.0%, 25g

(5-Amino-2-fluorophenyl)methanol, 95.0%, 1g

Ethyl 2-[(3-fluorophenyl)amino]acetate, 98%, 1g

cis-Epoxysuccinic Acid>97.0%(GC)(T)5g

(R,S)-Boc-3,3-dimethyl-proline, 99.9%, 250mg

Formic acid, min. 98%, for synthesis, 2.5 l, glass packaging

2-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-4-(trifluoromethyl)benzonitrile, 95.0%, 1g

(S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(4-(tert-butyl)phenyl)propanoic acid, 97%, 5g

Bicyclo[2.2.2]octane-1,4-diol, 98%, 100mg

2-(2,4-Dibromophenyl)acetic acid, 98.0%, 250mg

BENZYL-(3AR,6AR)-OCTAHYDROPYRROLO[3,2-B]PYRROLE-1-CARBOXYLATE, 95.0%, 50mg